Business · 24/08/2023Updated: 10/17/2026 · 1 min read
FDA Announces Public Advisory Committee Meeting for Endocrinologic and Metabolic Drugs
Summary
The Food and Drug Administration (FDA) is hosting a public meeting of its Endocrinologic and Metabolic Drugs Advisory Committee to gather input on regulatory issues, with a public comment period to follow.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →